STAT August 5, 2024
Frustrated by the lack of access to expensive weight loss drugs, North Carolina officials are urging the Biden administration to negotiate licenses with the manufacturers so that lower-cost alternatives can be made available.
The move comes after the North Carolina State Health Plan earlier this year dropped coverage because spending topped $102 million last year mostly for two drugs made by Novo Nordisk — Wegovy and Saxenda. A third drug called Zepbound that is made...
Today's Sponsors
Today's Sponsor